← Back to Search

Mobile-Aid Pain Reduction Intervention for Myofascial Pain Syndrome

N/A

Waitlist Available

Led By Pao-Feng Tsai, PhD

Research Sponsored by Kailea Manning

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (time 1), change from baseline at 6 weeks (time 2), and change from baseline at 12 weeks (time 3)

Awards & highlights

Study Summary

This trial tests a new pain-reducing intervention and its feasibility in people with myofascial pain syndrome of the low back. It will compare different levels of treatment to see if pain, activity, posture, and stress can be improved.

Eligible Conditions

Myofascial Pain Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (time 1), change from baseline at 6 weeks (time 2), and change from baseline at 12 weeks (time 3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (time 1), change from baseline at 6 weeks (time 2), and change from baseline at 12 weeks (time 3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 1), change from baseline at 6 weeks (time 2), and change from baseline at 12 weeks (time 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Depth of the Myofascial Trigger Point

Elasticity of the Myofascial Trigger Point

Pain pressure threshold (PPT)

+2 more

Secondary outcome measures

Anxiety

Depression

Get Up and Go (GUG)

+14 more

Trial Design

3Treatment groups

Active Control

Group I: No treatment conditionActive Control1 Intervention

Group 1 (no treatment condition) will only receive educational materials through email and a weekly phone call from Coordinator to reduce dropouts for 12 weeks.

Group II: Multiple component mobile-aid pain reduction intervention + sham osteopathic manipulation treatmentActive Control2 Interventions

Group 2 will receive the new intervention and sham osteopathic manipulative treatment for 12 weeks.

Group III: Multiple component mobile-aid pain reduction intervention + osteopathic manipulation treatmentActive Control2 Interventions

Group 3 will receive both the multiple component mobile-aid pain reduction intervention and actual osteopathic manipulation treatment for 12 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kailea ManningLead Sponsor

Edward Via Virginia College of Osteopathic MedicineOTHER

15 Previous Clinical Trials

2,235 Total Patients Enrolled

Pao-Feng Tsai, PhDPrincipal InvestigatorAuburn University

2 Previous Clinical Trials

85 Total Patients Enrolled

Media Library

Multiple Component Mobile-Aid Pain Reduction Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05860205 — N/A

Myofascial Pain Syndrome Research Study Groups: No treatment condition, Multiple component mobile-aid pain reduction intervention + sham osteopathic manipulation treatment, Multiple component mobile-aid pain reduction intervention + osteopathic manipulation treatment

Myofascial Pain Syndrome Clinical Trial 2023: Multiple Component Mobile-Aid Pain Reduction Intervention Highlights & Side Effects. Trial Name: NCT05860205 — N/A

Multiple Component Mobile-Aid Pain Reduction Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860205 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are seniors aged 75 and above eligible to partake in this experiment?

"Inclusion criteria for this trial limits eligibility to adults between 18 and 64 years of age."

Answered by AI

May I join this research initiative?

"Prospective patients must be aged 18 to 64 and have myofascial pain syndrome in order to meet the qualifications of this trial. The researchers are aiming to recruit 30 individuals for their study."

Answered by AI

Are there available slots for individuals to participate in this research?

"The details provided on clinicaltrials.gov suggest that this study is no longer actively recruiting participants, the trial having been first posted on May 1st 2023 and last updated on May 5th of the same year. Despite this particular medical trial ceasing recruitment, there are an additional 1537 trials presently looking for volunteers."

Answered by AI

What is the intended outcome of this investigative research project?

"The primary outcome evaluated through baseline (Time 1), 6-week modification (Time 2), and 12-week change from baseline measurements, is Pain Pressure Threshold. Supplementary objectives comprise of Physical Functioning/Quality of Life rated by the PROMIS Short Form 6b which runs on a minimum score of six to maximum thirty; higher scores suggest worse physical performance and quality of life. Sleep Disturbance, measured by the PROMIS short form 6a scoring system between minimum six to maximum thirty – with elevated scores indicating more sleep disturbance - as well as Sleep duration determined via NIH Common Data Element question focusing on lower durations being associated"

Answered by AI

Recent research and studies

Pain MedicineJournal

Prevalence of Myofascial Pain Syndrome in Chronic Non-specific Neck Pain: A Population-based Cross-sectional Descriptive Study

Cerezo-Téllez, Ester, María Torres-Lacomba, Orlando Mayoral-del Moral, Beatriz Sánchez-Sánchez, Jan Dommerholt, and Carlos Gutiérrez-Ortega. 2016. “Prevalence of Myofascial Pain Syndrome in Chronic Non-specific Neck Pain: A Population-based Cross-sectional Descriptive Study”. Pain Medicine. Oxford University Press (OUP). doi:10.1093/pm/pnw114.

clinicaltrials.govStudy

A Multiple Component Mobile-aid Pain Reduction Intervention to Decrease Myofascial Pain

Kailea Manning 2023. "A Multiple Component Mobile-aid Pain Reduction Intervention to Decrease Myofascial Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05860205.